產(chǎn)品名稱：MLFC小鼠肺成纖維細(xì)胞、MLFC小鼠肺成纖維細(xì)胞、MLFC小鼠肺成纖維細(xì)胞、MLFC小鼠肺成纖維細(xì)胞；

populations in the tumor masses including CD4+, CD8+, and regulatory T cells in addition to natural killer cells. Results: No adverse eklects were detected in any of the treated groups. Survival analysis indicated that the groups receiving dual or triple therapies had prolonged